Takeda Pharmaceutical announced it has entered into an agreement to acquire Shire for approximately 46 billion pounds, or 49.01 pounds per Shire share.
Takeda also announced a “364-day bridge credit agreement” for an aggregate principal amount of up to $30.85 billion to fund the acquisition. Under the terms of the acquisition, every Shire shareholders will be entitled to $30.33 in cash for each Shire share and either 0.839 new Takeda shares or 1.678 Takeda American depositary shares, according to company press releases.
After closing, Takeda shareholders will own approximately 50%
Uncategorized